Steadfast Capital Management LP Abbott Laboratories Transaction History

Steadfast Capital Management LP

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 16, 2022	SELL	$114.02 - $139.04 $2.5 Million - $3.05 Million	-21,924 Closed	0 $0
Q4 2021 Feb 14, 2022	SELL	$115.53 - $141.46 $191 Million - $233 Million	-1,650,130 Reduced 98.69%	21,924 $3.09 Million
Q4 2021 Feb 14, 2022	SELL	$115.53 - $141.46 $30.5 Million - $37.3 Million	-263,979 Reduced 13.64%	1,672,054 $235 Million
Q3 2021 Nov 15, 2021	SELL	$116.66 - $129.06 $17.5 Million - $19.3 Million	-149,705 Reduced 7.18%	1,936,033 $229 Million
Q2 2021 Aug 16, 2021	BUY	$105.79 - $124.53 $80.6 Million - $94.9 Million	761,858 Added 57.55%	2,085,738 $242 Million
Q1 2021 May 17, 2021	BUY	$108.84 - $128.23 $144 Million - $170 Million	1,323,880 New	1,323,880 $159 Million

3,185

1.3B

8.74M

8.08M

Ticker ABT
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 1,751,219,968
Market Cap $208B
Description
Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...

Get notified when there are updates to the investment portfolio of Steadfast Capital Management LP, based on Form 13F filings with the SEC.

Stay updated on Steadfast Capital Management LP with notifications on news.